Harvard Medical School’s Prof. Alfred Goldberg delivers inaugural speech

Harvard Medical School's Prof. Alfred Goldberg delivers inaugural speech at Ubiquigent, Medical Research Council, University of Dundee sponsored ubiquitin system drug discovery lecture Dundee, UK, 14th June 2012 - Ubiquigent Ltd was honoured today to have Professor Alfred Goldberg, Professor of… Read more

Stemgent announces formation of Ubiquigent, a new UK-listed biotechnology company based in Dundee, Scotland

New Venture co-founded with Professor Sir Philip Cohen to Focus on the Ubiquitin Proteasome Pathway, a Key Cell Signalling System with Significant Drug Discovery Potential Boston, MA, San Diego, CA, USA, March 3, 2010 - Stemgent, Inc., a biotechnology company… Read more